Sofinnova News
In Memory of Denis Lucquin
We are deeply saddened by the passing of Denis Lucquin, our former Chairman and one of the principal architects of Sofinnova Partners.
Denis joined Sofinnova in 1991 and spent more than three decades building something lasting. He had the conviction, early on, that life sciences was where this firm belonged and the persistence to make it so. He also saw the potential of industrial biotech before most, and built that strategy from the ground up. The firm we are today reflects his vision.
But Denis was more than his achievements. He was warm, direct, and curious, the kind of person everyone wanted to be around. He had a rare ability to see potential in people and in ideas before others did, and he acted on it. That quality shaped Sofinnova as much as any investment decision.
Our thoughts are with his wife, his sons, his grandchildren, and all who had the privilege of knowing him.
He will be greatly missed.
Related News
Sofinnova Partners closes €650M ($750M) Capital XI, greatly exceeding initial target to back early-stage healthcare deals
Sofinnova Partners collaborates with NVIDIA to accelerate European life sciences startups
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
Amid the buzz at JP Morgan conference, Sofinnova Partners' Antoine Papiernik is optimistic